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Protein structure-based drug design has been contributing
to the drug discovery process since the early 1990s. Struc-
tural knowledge on the exact interactions of drugs with
their target proteins has been applied mainly to predict
potency changes of chemically modified lead com-
pounds.
With the 3D-structural information available today, addi-
tional aspects of the drug discovery process become pre-
dictable. Target-based virtual screening is being applied to
identify new unexpected lead structures. Selectivity of
compounds between homologous or orthologous pro-
teins can be predicted, offering new possibilities to design
selective compounds or predict the suitability of animal
models for pharmacodynamic studies. Also the number of
x-ray structures of proteins relevant for ADMET properties
of drug molecules has remarkably increased during the
last few years. This development offers the possibility to
modulate or rationally design out unwanted ADMET
properties. This covers aspects such as plasma protein
binding, cytochrome P450 inhibition, metabolism and
induction.
In this review style talk, a number of recent examples will
be presented that demonstrate the utility of protein struc-
ture information during the drug discovery process, from
lead identification to lead optimization and from phar-
macodynamics to pharmacokinetic studies.
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